Asahi Intecc (7747) Q2 2026 earnings summary

Executive summary

• Net sales for the first half of FY2026 reached ¥71,266 million, up 15.9% year-over-year, driven by strong demand in both Medical and Device Divisions.

• Operating profit rose 40.1% to ¥24,372 million, with ordinary profit up 43.5% to ¥24,143 million and net income attributable to shareholders up 40.4% to ¥17,214 million.

• Gross profit margin improved from 67.6% to 70.6% due to productivity gains, and extraordinary income rose from gains on sale of investment securities.

Financial highlights

• Gross profit grew 21.1% year-over-year to ¥50,311 million.

• EPS increased 43.0% to ¥64.56.

• SGA expenses rose 7.4% year-over-year, mainly from increased sales promotion and R&D.

• Comprehensive income nearly doubled year-over-year to ¥24,378 million.

• Net assets rose to ¥158,671 million, with an equity-to-asset ratio of 80.6%.

Outlook and guidance

• Full-year forecast for FY ending June 30, 2026, was revised upward: net sales expected at ¥141,142 million (+17.6%), operating profit at ¥42,220 million (+40.4%), and profit attributable to owners of parent at ¥30,556 million (+139.9%).

• Dividend forecast for FY ending June 30, 2026, raised to ¥46.10 per share, including a ¥5.79 commemorative dividend.